Eckert & Ziegler SE

EUZ

DE0005659700

Office Equipment

Market Closed - Xetra Other stock markets 11:35:05 2024-05-17 EDT			5-day change	1st Jan Change
46.5 ^EUR	-0.21%		+16.25%	+12.59%

05-15	ECKERT & ZIEGLER : Hauck & Aufhauser reiterates its Buy rating	ZD
05-14	Eckert & Ziegler SE Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Eckert & Ziegler SE Reaffirms Earnings Guidance for the Year 2024

April 22, 2024 at 08:49 am

Eckert & Ziegler SE reaffirmed earnings guidance for the year 2024. The company expects sales of just under EUR 265 million. The forecast for the 2024 financial year published on March 22, 2024 remains unchanged.

Latest news about Eckert & Ziegler SE

ECKERT & ZIEGLER : Hauck & Aufhauser reiterates its Buy rating	05-15	ZD
Eckert & Ziegler SE Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
ECKERT & ZIEGLER : Hauck & Aufhauser maintains a Buy rating	04-24	ZD
Eckert & Ziegler increases profit at the start of the year - targets confirmed	04-22	DP
Eckert & Ziegler SE Reaffirms Earnings Guidance for the Year 2024	04-22	CI
RLS Radiopharmacies Partners with Eckert & Ziegler SE to Expand Production of Gallium-68-Based Radiopharmaceuticals	04-04	CI
Transcript : Eckert & Ziegler Strahlen- und Medizintechnik AG, 2023 Earnings Call, Mar 22, 2024	03-22
Eckert & Ziegler SE Reports Earnings Results for the Full Year Ended December 31, 2023	03-22	CI
Eckert & Ziegler recovers - Dividend disappointed - 'Balance sheet strong'	03-20	DP
Eckert & Ziegler cuts dividend in favor of investments	03-20	DP
ECKERT & ZIEGLER : Receives a Buy rating from Hauck & Aufhauser	03-20	ZD
Eckert & Ziegler plans further growth - dividend decreases significantly	03-19	DP
Eckert & Ziegler Strahlen- und Medizintechnik AG(XTRA:EUZ) added to Germany TECDAX Index (Price Return)	03-17	CI
Eckert & Ziegler Strahlen- und Medizintechnik AG(XTRA:EUZ) added to Germany TECDAX (Total Return) Index	03-17	CI
Deutsche Börse's Stoxx to Make Changes to DAX Indices	03-06	MT
Index changes move - MDax ejection weighs on Rational	03-06	DP
ECKERT & ZIEGLER : Gets a Buy rating from Hauck & Aufhauser	03-06	ZD
Eckert & Ziegler to Supply Nucleus RadioPharma with Therapeutic Radioisotopes Ac-225 and Lu-177	01-31	CI
ECKERT & ZIEGLER : Hauck & Aufhauser gives a Buy rating	01-03	ZD
ECKERT & ZIEGLER : Hauck & Aufhauser keeps its Buy rating	12-07	ZD
Chairman of the Supervisory Board of Eckert & Ziegler moves to subsidiary Pentixapharm	11-21	DP
Eckert & Ziegler AG Announces Executive Changes	11-21	CI
ECKERT & ZIEGLER : Hauck & Aufhauser keeps its Buy rating	11-20	ZD
Eckert & Ziegler Strahlen- und Medizintechnik AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-14	CI
ECKERT & ZIEGLER : Hauck & Aufhauser keeps its Buy rating	11-08	ZD

Chart Eckert & Ziegler SE

Duration

Period

More charts

Company Profile

Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.

Sector

Office Equipment

Calendar

2024-05-28 - Ex-dividend day for final dividend

More about the company

Income Statement Evolution

More financial data

Ratings for Eckert & Ziegler SE

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

46.5 EUR

Average target price

62.5 EUR

Spread / Average Target

+34.41%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Scientific & Precision Equipment

	1st Jan change	Capi.
ECKERT & ZIEGLER SE	+12.59%	1.05B
SHIMADZU CORPORATION	+10.58%	8.35B
TECAN GROUP AG	-2.97%	4.86B
JEOL LTD.	+5.75%	2.17B
NINGBO YONGXIN OPTICS CO.,LTD	-28.18%	1.09B
PARK SYSTEMS CORP.	-2.65%	862M
FOCUSED PHOTONICS (HANGZHOU), INC.	-22.90%	754M
PHENIX OPTICAL COMPANY LIMITED	-22.96%	677M
MLOPTIC CORP.	-55.35%	674M
SVG TECH GROUP CO.,LTD.	-30.18%	595M

Scientific & Precision Equipment